Your browser doesn't support javascript.
loading
Metabolic drivers of non-alcoholic fatty liver disease.
Bence, Kendra K; Birnbaum, Morris J.
Affiliation
  • Bence KK; Internal Medicine Research Unit, Pfizer Worldwide Research, Development, and Medical, Cambridge, MA, USA. Electronic address: kendrakathleen.bence@pfizer.com.
  • Birnbaum MJ; Internal Medicine Research Unit, Pfizer Worldwide Research, Development, and Medical, Cambridge, MA, USA.
Mol Metab ; 50: 101143, 2021 08.
Article in En | MEDLINE | ID: mdl-33346069
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adipose Tissue / Metabolic Syndrome / Non-alcoholic Fatty Liver Disease / Liver Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Mol Metab Year: 2021 Document type: Article Country of publication: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adipose Tissue / Metabolic Syndrome / Non-alcoholic Fatty Liver Disease / Liver Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Mol Metab Year: 2021 Document type: Article Country of publication: Germany